Welcome back to the Dispotech, your disposable excellence blog, where you’ll find all the news, interesting anecdotes and innovations in the medical field.
Today, based on an article published on medgadget.com, we’ll be speaking of a revolutionary medical device that could replace vaccine injections. Would you like to know more about it? Read the article and discover Nanopatch, an extraordinary technology.
David Hoey is the CEO and director of Vaxxas, a company working on enhancing the performance of existing and future vaccines using a delivery technology called Nanopatch.
The Nanopatch approach consists of using a medical device which, to the eye, appears to be an adhesive bandage. Actually, when seen under a microscope, it is a tiny pattern which contains hundreds of microcolumns of vaccine cells. Once the microprojections of the columns come into contact with the outermost layer of the skin, they imperceptibly perforate it, injecting the cells into the human body. During the latest TEDMED conference, Hoey spoke of the product and all the research that Vaxxas is advancing, redefining the boundaries of vaccination technology every day.
Hoey explained that he became interested in vaccine research mainly because he enjoys working with technologies that change the everyday lives of people. Nanopatch is a nano-adhesive bandage that has the potential to improve the performances of vaccines on human beings and is an interesting product for both the commercial market as well as the research sector.
What are the advantages of a Nanopatch compared to a traditional needle vaccine? Nanopatch was developed to deposit the antigens of a vaccine just beneath the skin surface, with all the other cells.
This allows the antigens to be effectively and properly trafficked to lymph nodes in order to be “processed”. Delivered in this way, the vaccine antigens produce an immune response equivalent to one done with a normal syringe injection. Currently around twenty vaccines can be delivered with Nanopatch.
One of the most important and debated aspects of this innovative medical device is how they are administered: Potentially Nanopatch has what it takes in order to be self-administered – without the intervention of a healthcare provider. Nonetheless, precise regulations are necessary – which often differ from region to region, and nation to nation.
Research at Vaxxas continues and who knows? Maybe in a few years, we’ll be able to vaccinate ourselves thanks to Nanopatch!
What do you think of this medical device? Have your say by contacting Dispotech!